Front. Immunol. Frontiers in Immunology Front. Immunol. 1664-3224 Frontiers Media S.A. 10.3389/fimmu.2025.1745867 Correction Correction: TACE-HAlC combined with Donafenib and immune checkpoint inhibitors for BCLC stage C HCC patients (THEME study): a retrospective IPTW-adjusted cohort study YinLinan 1 † Writing – original draft Writing – review & editing LiWeihang 1 † ShaoWencheng 2 HouXunbo 1 LiuBowen 1 LiuXuesong 1 LiuRuibao 1 * HuangPeng 3 * Department of Interventional Radiology, Harbin Medical University Cancer Hospital, Harbin, China Department of Radiation Physics, Harbin Medical University Cancer Hospital, Harbin, China Department of Gastroenterology, Harbin Medical University Cancer Hospital, Harbin, China Correspondence: Ruibao Liu, Liu_ruibao@sina.com; Peng Huang, huangpeng2002–@163.com

These authors have contributed equally to this work and share first authorship

 20 11 2025 2025 16 1745867 13 11 2025 14 11 2025 Copyright © 2025 Yin, Li, Shao, Hou, Liu, Liu, Liu and Huang. 2025 Yin, Li, Shao, Hou, Liu, Liu, Liu and Huang https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. A Correction on TACE-HAlC combined with Donafenib and immune checkpoint inhibitors for BCLC stage C HCC patients (THEME study): a retrospective IPTW-adjusted cohort study By Yin L, Li W, Shao W, Hou X, Liu B, Liu X, Liu R and Huang P (2025) Front. Immunol. 16:1669856. doi: 10.3389/fimmu.2025.1669856 hepatocellular carcinoma Donafenib transarterial chemoembolization hepatic arterial infusion chemotherapy immune checkpoint inhibitors section-at-acceptance Cancer Immunity and Immunotherapy

Author “Peng Huang” was erroneously assigned as corresponding author. The correct corresponding author is “Peng Huang and Ruibao Liu”.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland